2 High-Yield Stocks to Buy in October Without Any Hesitation
Investors aren't giving Medtronic credit for its turnaround, and McCormick is gearing up for a major business expansion.
When seeking reliable investments, I prioritize historically sound companies with a track record of strong yields. One such example is Medtronic, a leading medical device manufacturer. I purchased a significant stake in this company a few years ago, even before its recent surge. Now, I am pleased to report that I have doubled my investment in Medtronic, as the business continues to thrive and deliver consistent dividend growth.
With a remarkable 49-year history of raising dividends, Medtronic is on the cusp of achieving Dividend King status, a testament to its solid financial foundation. As we begin October, I highly recommend Medtronic as a dependable long-term dividend buy.
Another noteworthy addition to my portfolio is McCormick, a renowned flavor specialist. Recently, I increased my position in this company as it announced plans to acquire Unilever's (NYSE: UL) food business. This strategic acquisition promises to bring substantial benefits to McCormick, making it an even more attractive investment option.
With its robust financial performance and commitment to shareholder value, McCormick is an excellent long-term dividend investment that I strongly endorse as we embark on the month of October.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
